Pharma in review: trending stories 6/28/19

Jun 28, 2019

number1

Merck begins hunt for new CEO

The drugmaker is scouting for a replacement for its CEO, Kenneth Frazier.


number2Sun Pharma hit with Form 483 for Halol facility
The drugmaker said it has received four observations from the U.S. FDA for its Halol facility in Gujarat.

number3FDA rejects Daiichi Sankyo's blood cancer treatment

Just days after receiving approval in Japan, Daiichi Sankyo said the U.S. FDA will not approve its drug, quizartinib.

number4

Pharma's budding opportunity

Why the industry is forming bonds with CBD

number5

Report: Pfizer passed on promising Alzheimer's research

The drugmaker admitted that studies showed its rheumatoid arthritis medication Enbrel could potentially reduce the risk of Alzheimer’s by 64 percent.

 

Don't miss your Daily Dose. Sign up to get news like this delivered right to your inbox.